National Institutes of Health

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing February 17, 2028.